Table 5 Documented treatment with clozapine lifetime.

Age at time of LP

68/263

38.75 ± 17.45

37.40 ± 15.08

0.586

94.48

0.559^a

Duration of illness (months)

66/211

123.53 ± 135.98

55.82 ± 83.74

3.83

80.98

<0.001^a

Age at onset of disease (years)

65/229

28.94 ± 12.63

33.64 ± 13.87

−2.456

292

0.015^a

Gender (f/m)

331

29/39

114/149

0.011

1

0.917^b

Protein level (mg/dl)

328

41.45_(N = 68)± 17.26

38.13_{(N = 260)}± 14.30

1.63

326

0.104^a

Protein level elevated (yes/no)

328

19/49

46/214

3.56

1

0.059^b

Albumin ratio

330

6.37_(N = 68) ± 3.05

5.72_{(N = 262)} ± 2.48

1.81

328

0.071^a

Albumin ratio elevated (yes/no)

330

22/46

75/187

0.361

1

0.548^b

White blood cell count (cells/µl)

329

1.72_(N = 68) ±1.91

1.52_{(N = 261)}±1.77

0.839

327

0.402^a

Pleocytosis (> 4/µl) (yes/no)

329

7/61

13/248

2.667

1

0.102^b

Pleocytosis (> 5/µl) (yes/no)

329

4/64

8/253

0.279^c

Pleocytosis (> 6/µl) (yes/no)

329

3/65

5/256

0.369^c

OCB (yes/no)

329

24/44

98/163

0.117

1

0.732^b

OCB intrathecal synthesis (yes/no)

122

10/14

29/69

1.292

1

0.256^b